Palumbo Wealth Management’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-57,849
Closed -$137K 246
2026
Q1
$137K Buy
57,849
+19,798
+52% +$68.6K 0.03% 215
2025
Q4
$197K Buy
+38,051
New +$184K 0.05% 210
2025
Q3
Sell
-41,060
Closed -$150K 213
2025
Q2
$150K Buy
41,060
+2,394
+6% +$8.92K 0.05% 190
2025
Q1
$167K Buy
38,666
+18,476
+92% +$74.6K 0.06% 172
2024
Q4
$64.6K Buy
+20,190
New +$67.7K 0.02% 171
2024
Q1
Sell
-11,132
Closed -$45.5K 143
2023
Q4
$45.5K Buy
+11,132
New +$31.2K 0.02% 120

Other funds holding ORGO

Palumbo Wealth Management's ORGO Position: Q2 2026 in Review

Palumbo Wealth Management sold out of Organogenesis Holdings (ORGO) in Q2 2026, closing a stake of 57,849 shares — an estimated $137K sold.

Palumbo Wealth Management first reported a position in ORGO in Q4 2023 and held it in 6 quarters. The position peaked at $197K in Q4 2025. 136 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Palumbo Wealth Management reported no remaining Organogenesis Holdings position as of Q2 2026 after selling out during the quarter.
  • Palumbo Wealth Management sold 57,849 Organogenesis Holdings shares in Q2 2026, an estimated $137K.
  • Palumbo Wealth Management first reported a position in Organogenesis Holdings in Q4 2023 and held it in 6 quarters.
  • Palumbo Wealth Management's Organogenesis Holdings position peaked at $197K in Q4 2025.
  • 136 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Palumbo Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.